Efficacy and safety of regenerative cell therapy for pulmonary arterial hypertension in animal models: a preclinical systematic review protocol

BACKGROUND: Pulmonary arterial hypertension (PAH) is a rare disease (15 cases per million) that is characterized by widespread loss of the pulmonary microcirculation and elevated pulmonary vascular resistance leading to pathological right ventricular remodeling and ultimately right heart failure. Re...

Descripción completa

Detalles Bibliográficos
Autores principales: Suen, Colin M., Zhai, Alex, Lalu, Manoj M., Welsh, Christopher, Levac, Brendan M., Fergusson, Dean, McIntyre, Lauralyn, Stewart, Duncan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4880876/
https://www.ncbi.nlm.nih.gov/pubmed/27225668
http://dx.doi.org/10.1186/s13643-016-0265-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4880876/
https://www.ncbi.nlm.nih.gov/pubmed/27225668
http://dx.doi.org/10.1186/s13643-016-0265-x

Ejemplares similares